%PDF-1.4
%
79 0 obj
<>
endobj
76 0 obj
<>
endobj
188 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-04-13T15:18:51Z
2024-03-28T05:20:12-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T05:20:12-07:00
application/pdf
Heather
2003-250.april
uuid:07dbcedc-1dd2-11b2-0a00-bb0927fd5800
uuid:07dbcede-1dd2-11b2-0a00-6a0000000000
endstream
endobj
65 0 obj
<>
endobj
66 0 obj
<>
endobj
80 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
35 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 57 0 R/Type/Page>>
endobj
38 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 59 0 R/Type/Page>>
endobj
211 0 obj
[215 0 R]
endobj
212 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(evidence for independent production. J Immunol )Tj
0 Tc 0 Tw 0 -1.25 TD
(1988;141:2407-12.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(25.)-875.1 (Gilliam MB, Sherman MP)110.7 (, Griscavage JM, Ignarro IJ. )54.8 (A)]TJ
2.175 -1.25 Td
(spectrophotometric assay for nitrate using NADPH oxidation by)Tj
T*
[(Asper)17.7 (gilus nitrate reductase. )54.8 (Anal Biochem 1993;212:359-65.)]TJ
-2.175 -1.25 Td
[(26.)-875.1 (T)69.9 (eixeira SA, Castro GM, Papes F)79.7 (, et al. Expression and activity of)]TJ
2.175 -1.25 Td
(nitric oxide synthase isoforms in rat brain during the development)Tj
T*
[(of experimental aller)17.7 (gic encephalomyelitis. Brain Res Mol Brain)]TJ
0 Tc T*
(Res 2002;99:17-25.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(27.)-875.1 (Laemmli UK. Cleavage of structural proteins during the assembly)]TJ
2.175 -1.25 Td
[(of the head of bacteriophage )17.7 (T4. Nature 1970;227:680-5.)]TJ
-2.175 -1.25 Td
[(28.)-875.1 (Bradley PP)110.7 (, Priebat DA, Christensen RD, Rothstein G.)]TJ
2.175 -1.25 Td
(Measurement of cutaneous inflammation: estimation of neutrophil)Tj
T*
[(content with an enzyme marker)54.8 (. J Invest Dermatol 1982;78:206-9.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Farrel )54.8 (AJ, Blake DR, Palmer RMJ, Moncada S. Increased )]TJ
2.175 -1.25 Td
(concentrations of nitrite in SF and serum samples suggest increased)Tj
T*
[(nitric oxide synthesis in rheumatic diseases. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1992;51:1219-22.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(30.)-875.1 (Ueiki )36.8 (Y)128.9 (, Miyake S, )17.7 (T)69.9 (ominaga )36.8 (Y)128.9 (, et al. Increased nitric oxide levels)]TJ
2.175 -1.25 Td
(in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-6)Tj
-2.175 -1.25 Td
[(31.)-875.1 (Borderie D, Hilliquin P)110.7 (, Hernvann )54.8 (A, et al. Nitric oxide synthase is)]TJ
2.175 -1.25 Td
(expressed in the lymphomononuclear cells of synovial fluid in)Tj
T*
(patients with rheumatoid arthritis. J Rheumatol 1999;26:2083-8.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Hilliquin P)110.7 (, Borderie D, Hernvann )54.8 (A, et al. Nitric oxide as )]TJ
2.175 -1.25 Td
[(S-nitrosoproteins in rheumatoid arthritis. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1997;40:1512-7.)Tj
-0.00011 Tc 0.02499 Tw 30.825 31.25 Td
[(33.)-875.1 (T)69.9 (oprakci M, Ozmen D, Mutaf I, et al. )54.8 (Age-associated changes in)]TJ
2.175 -1.25 Td
(nitric oxide metabolites nitrite and nitrate. Int J Clin Lab Res)Tj
0 Tc 0 Tw T*
(2000;30:83-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(34.)-875.1 (T)69.9 (sukahara H, Hiraoka M, Hori C, Miyanomae )17.7 (T)74 (,)-0.1 ( Kikuchi K, Sudo)]TJ
2.175 -1.25 Td
[(M. )54.8 (Age-related changes of urinary nitrite/nitrate excretion in)]TJ
T*
(normal children. Nephron 1997;76:307-9.)Tj
-2.175 -1.25 Td
[(35.)-875.1 (Min BH, Kim HJ, Lim H, Park CS, Park SR. Ef)17.7 (fects of ageing and)]TJ
2.175 -1.25 Td
(arthritic disease on nitric oxide production by human articular)Tj
T*
(chondrocytes. Exp Mol Med 2001;33:299-302.)Tj
-2.175 -1.25 Td
[(36.)-875.1 (Bender JG, )17.7 (V)110.8 (an Epps DE, Searles R, )17.7 (W)39.9 (illiams RC. )54.8 (Altered function)]TJ
2.175 -1.25 Td
(of synovial fluid granulocytes in patients with acute inflammatory)Tj
T*
(arthritis: evidence for activation of neutrophils and its mediation by)Tj
T*
(a factor present in synovial fluid. Inflammation 1986;10:443-53.)Tj
-2.175 -1.25 Td
[(37.)-875.1 (Beckman JS, Beckman )17.7 (TW)91.7 (, Chen J, Marchall P)91.7 (A, Freeman BA.)]TJ
2.175 -1.25 Td
(Apparent hydroxyl radical production by peroxynitrite:)Tj
T*
(Implications for endothelial injury from nitric oxide and )Tj
T*
[(superoxide. Proc Natl )54.8 (Acad Sci USA)-220.2 (1990;87:1620-4. )]TJ
-2.175 -1.25 Td
[(38.)-875.1 (Hanafy KA, Krumenacker JS, Murad F)79.7 (. NO, nitrotyrosine, and)]TJ
2.175 -1.25 Td
[(cyclic GMP)-238.2 (in signal transduction. Med Sci Monit 2001;7:801-19.)]TJ
-2.175 -1.25 Td
[(39.)-875.1 (Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative)]TJ
2.175 -1.25 Td
(damage in chronic inflammation. Nitrotyrosine in serum and)Tj
T*
(synovial fluid from rheumatoid patients. Febs Lett 1994;350:9-12.)Tj
-2.175 -1.25 Td
[(40.)-875.1 (Migita K, )36.8 (Y)99.8 (amasaki S, Ida M, et al. )17.7 (The role of peroxynitrite in)]TJ
2.175 -1.25 Td
(cyclooxygenase-2 expression of rheumatoid synovium. Clin Exp)Tj
T*
(Rheumatol 2002;20:59-62.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
8 0 0 8 54.5 35.9844 Tm
(Lotito, et al: NO in JIA)Tj
0 Tc 0 Tw 61.4375 -0.0313 Td
(997)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
59 0 obj
<>stream
8;Z\4;6Iej#kS!JaE=)C`SdPfl_`cRHamikAJ>OibR0'-"57;dhqH=>Jc7X#%?KQ!
P?=nq*?boVp>_]j+tj4a3S=9MR9ED-:X#>(Y6!YPG(@%%@tK/h=n1]agT+ci-e`gu
\dup2,gs$I6%0SdJCDlWpPOAkI"d/'1)93cA&MP]&4-%ftgl;c&>6bnjqH.
;i*S9_^l,&5TZ-&7rTh!2<[_b+m@'O0*g=8^
iLG'T)j03S":S6ANJT>Q$eq=q0ABZ05KEtjqJ,U1]9DPnL^:K$C?B*
endstream
endobj
63 0 obj
[/Indexed/DeviceRGB 255 62 0 R]
endobj
62 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
87 0 obj
<>
endobj
82 0 obj
<>
endobj
118 0 obj
<>
endobj
193 0 obj
<>
endobj
83 0 obj
<>
endobj
110 0 obj
<>stream
HT{PSg{# ! U|(UAQ"+<D$<
@"*OEP*ʪ[btVS=7~tvvf|;s·cq-A>I2h(m|+댱.8Ђu%ש(k%kf>B77\ҵwY{kͅKvgVyzyyo(D rfyoU7]֮g72[1BL.ȘɱҴiZ\0[bVƤ e´sfiqBItZ#gER"ElD'} McDf,=F&EվB>0Kk ,E5l+I1Lcj+İ6awql*b$s\99D=km2KfbKӜs^Y'Ysƹ-sby?$؎unkZ``>GiSߝ
4Q->/CKX~ c: G~E@rY4œW1'g[Ҹ
$p˨kpBP5;Q)ff@as_L/;J4mejW6ê.5K6|ܐS*
W#k 7MC*ro^rԷ73f@k.>Z6LOPN@MmjxRPT $]t6eE+l۞Oezg&`($܊ƎFcZMQbf} gsc"ztG+kea=I]l* {R
U[ͅNݗ?K'|Ȋ$YTgWh+u}7k!j> ًc6\zF:<ß~O
)l-(`8Ya\}%HxA<*/T:Ukeg[j0LazSDp$$)()+ռx+0`=MѳnlEP*j N>.v|(d֟F܃i2cqx|`cL4#%+$tRoرM
o'D|u~arMNMNWd|r!-k|pr-x0LPKVm썼\0L6L.(Zݻ/2!."'PMZEyBɐ
!KC{(DҺ̓26[w #nol-l( N{E,9=ybM=$_+]><
:u59`